IL-13 Controls IL-33 Activity through Modulation of ST2

Area of Science:

• Immunology
• Inflammation research
• Cytokine signaling

Background:

• Interleukin-33 (IL-33) is a key cytokine in local inflammation, acting on cells like ILC2s, Th2 cells, and mast cells.
• IL-33 signaling is modulated by transmembrane ST2L and its decoy receptor, soluble ST2 (sST2).
• Previous studies suggested a role for IL-13 in modulating IL-33 responsiveness, but the precise mechanisms were unclear.

Purpose of the Study:

• To investigate the regulatory role of IL-13 on IL-33 activity.
• To determine if IL-13 modulates the expression of transmembrane ST2L and soluble ST2 (sST2).
• To elucidate the cellular mechanisms by which IL-13 influences IL-33-mediated responses.

Main Methods:

• Utilized Il13 knockout (Il13^-/-) mice and wild-type (WT) littermates.
• Administered IL-33 intraperitoneally (i.p.) to assess inflammatory and immune responses.
• Analyzed splenomegaly, immune cell populations in the peritoneum and spleen, eosinophilia, sST2 levels, and gene expression of ST2 isoforms in various tissues.

Main Results:

• Il13^-/- mice exhibited exacerbated responses to IL-33 compared to WT mice.
• IL-33 administration led to heightened splenomegaly, increased peritoneal immune cells including ST2L+ ILC2s, and elevated eosinophilia in Il13^-/- mice.
• Reduced levels of sST2 were observed in the circulation and peritoneum of Il13^-/- mice, with increased gene expression of both ST2 isoforms in spleen, lung, and liver.
• Fibroblasts were identified as IL-13-responsive cells that regulate IL-33 activity via sST2 production.

Conclusions:

• IL-13 plays a significant regulatory role in IL-33-mediated inflammation.
• IL-13 induces the production of the IL-33 decoy receptor sST2, thereby dampening IL-33 signaling.
• IL-13 also modulates ST2L+ ILC2 populations, further influencing the immune response to IL-33.